Pharmafile Logo

RTS,S

- PMLiVE

AbbVie’s long-term Rinvoq data shows continued repigmentation in non-segmental vitiligo

The use of Rinvoq in non-segmental vitiligo is under regulatory review by the US FDA

- PMLiVE

Who’s steering? Why pharma needs humans at the helm of AI

Understanding how AI decisions are made, who owns the outcomes and how accountability travels across partners and platforms

The Vector Issue 3 banner

Access The Vector Issue 3: 15 payers describe the likely affect of EU General Pharmaceutical Legislation on orphan drug strategy

In the third issue of The Vector, Genesis Research asked 15 payers across France, Germany, Italy, Spain, and the UK how they believe the new EU General Pharmaceutical Legislation will...

Genesis Research Group

- PMLiVE

Your AI pilot works. That’s the problem.

What breaks when you scale it won't be the model. It'll be your data.

11 London

- PMLiVE

“We’ve been told we can’t touch AI”

It's not been a great few weeks for anyone trying to make the calm, sensible case for AI tools. Researchers have been quitting the big labs, including Anthropic, and going...

11 London

- PMLiVE

Regeneron announces results for preventing lean mass and muscle loss during GLP-1 weight loss

Results show trevogrumab prevents lean mass and muscle loss during GLP-1 weight loss

- PMLiVE

The impact of AI and digital health on chronic diseases

Over the past decades, advances in information technology have fundamentally transformed the management of chronic diseases, but what impact is this having on the pharma industry?

- PMLiVE

Pfizer’s Litfulo significantly improved repigmentation in nonsegmental vitiligo

NSV is a chronic autoimmune disease where the immune system attacks melanin-producing cells, leading to a loss of pigment

- PMLiVE

Regulatory complexity: the challenges of navigating the new normal

How functional service provider models are helping pharma adapt to regulatory uncertainty

- PMLiVE

What 90 Minutes of Live AI Case Practice Revealed About Physician Readiness

At EHA 2026 in Stockholm, 425 hematologists and oncologists attended an independent, 90-minute Medscape symposium on the practical and ethical use of AI. The format was case-based. The faculty presented...

Medscape Education

- PMLiVE

AstraZeneca opens new global strategic R&D centre in US

The new centre will be home to nearly 2,000 world-class researchers and scientists

- PMLiVE

From ambition to action: realising the true value of health

Why industry needs to engage earlier, explain value more clearly, understand service pressures and take shared responsibility for implementation

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links